Declarations of interest by members of Health Canada's special advisory committees and panels: a descriptive study
J Lexchin - Canadian Medical Association Open Access Journal, 2019 - cmajopen.ca
Background: Health Canada supplements its in-house expertise on pharmacotherapy and
pharmaceutical policy through the use of scientific/expert advisory committees and …
pharmaceutical policy through the use of scientific/expert advisory committees and …
Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study
K Elder, KA Turner, L Cosgrove, J Lexchin, A Shnier… - Cmaj, 2020 - Can Med Assoc
BACKGROUND: The producers of clinical practice guidelines (CPGs) may not disclose
industry funding in their CPGs. We reviewed Canadian national CPGs to examine the …
industry funding in their CPGs. We reviewed Canadian national CPGs to examine the …
Association between commercial funding of Canadian patient groups and their views about funding of medicines: an observational study
J Lexchin - PLoS One, 2019 - journals.plos.org
Background Patient groups represent the interest of their members when it comes to drug
funding. Many patient groups receive grants from pharmaceutical companies that make …
funding. Many patient groups receive grants from pharmaceutical companies that make …
Contributors to primary care guidelines: What are their professions and how many of them have conflicts of interest?
GM Allan, R Kraut, A Crawshay, C Korownyk… - Canadian Family …, 2015 - cfp.ca
Objective To determine the professions of those who contribute to guidelines, guideline
variables associated with differing contributor participation, and whether conflict of interest …
variables associated with differing contributor participation, and whether conflict of interest …
Patient, family, and community advisory councils in health care and research: a systematic review
BJ Oldfield, MA Harrison, I Genao, AT Greene… - Journal of general …, 2019 - Springer
Background Patient-centeredness is a characteristic of high-quality medical care and
requires engaging community members in health systems' decision-making. One key patient …
requires engaging community members in health systems' decision-making. One key patient …
[PDF][PDF] Industry relationships among authors of US Clinical Practice Guidelines in cardiology from 2014 to 2020
Clinical practice guidelines and Scientific statements are influential publications that define
the standard of care for many diseases. However, little is known about industry payments …
the standard of care for many diseases. However, little is known about industry payments …
Towards transparency: adoption of WHO best practices in clinical trial registration and reporting among top medical research funders in the USA
E Gamertsfelder, ND Figueroa, S Keestra… - BMJ evidence-based …, 2024 - ebm.bmj.com
Objective To assess to what extent the clinical trial policies of the largest public and
philanthropic funders of clinical research in the United States meet WHO best practices in …
philanthropic funders of clinical research in the United States meet WHO best practices in …
How FDA Advisory Committee members prepare and what influences them
TD McIntyre, M Pappas, JJ DiBiasi - Therapeutic Innovation & Regulatory …, 2013 - Springer
Since 1992 many changes have occurred in the regulations, guidelines, and processes
governing the FDA, the biomedical industry, other stakeholders, and their interactions. Of …
governing the FDA, the biomedical industry, other stakeholders, and their interactions. Of …
Perspectives of non-specialists on the potential to serve as ethics committee members
C Kane, K Takechi, M Chuma… - Journal of …, 2019 - journals.sagepub.com
Objective In Japan, under the new Clinical Trials Act pertaining to investigator-initiated
clinical trials that came into effect on 1 April 2018, review boards should review proposed …
clinical trials that came into effect on 1 April 2018, review boards should review proposed …
Financial conflict of interest and academic influence among experts speaking on behalf of the pharmaceutical industry at the US food and drug administration's …
A Lammers, J Edmiston… - Mayo Clinic …, 2017 - mayoclinicproceedings.org
Methods We reviewed transcripts, presentation slides, and supplemental documents for all
Oncology Drug Advisory Committee (ODAC) meetings concerning a specific drug product …
Oncology Drug Advisory Committee (ODAC) meetings concerning a specific drug product …
